Surgical lung biopsy for interstitial lung disease: When considered necessary, should these be done in larger and experienced centres only?

TY - JOUR

T1 - Surgical lung biopsy for interstitial lung disease

T2 - When considered necessary, should these be done in larger and experienced centres only?

AU - Hutchinson, John

AU - Hubbard, Richard

AU - Raghu, Ganesh

N1 - Funding Information: Conflict of interest: J. Hutchinson has nothing to disclose. R. Hubbard has nothing to disclose. G. Raghu reports personal fees from and consultancy work on IPF studies for Boehringer Ingelheim, consultancy work on IPF studies for BMS, Bellerophan, Fibrogen, Gilead, Nitto, Promedior, Roche, Sanofi, Veracyte, Biogen, Genentech, and consultancy work on IPF studies and data and safety monitoring board work for Avalyn, and grants from NIH, outside the submitted work.

PY - 2019/2/1

Y1 - 2019/2/1

UR - https://www.scopus.com/pages/publications/85061958420

U2 - 10.1183/13993003.00023-2019

DO - 10.1183/13993003.00023-2019

M3 - Review article

C2 - 30792236

AN - SCOPUS:85061958420

SN - 0903-1936

VL - 53

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 2

M1 - 1900023

ER -